## Abstract Sera from 20 Chinese patients with chronic hepatitis B were examined for hepatitis B e antigen and hepatitis B virus (HBV) DNA. There was considerable discordance with HBV DNA not being detectable in 10 out of 13 (77%) patients who were hepatitis B e antigen positive. Further testing fo
Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B
✍ Scribed by Pisit Tangkijvanich; Piyawat Komolmit; Varocha Mahachai; Pattaratida Sa-nguanmoo; Apiradee Theamboonlers; Yong Poovorawan
- Book ID
- 118088215
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 234 KB
- Volume
- 40
- Category
- Article
- ISSN
- 1386-6346
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegylated interferon (PEG-IFN). We investigated within a large randomized trial whether quantitative HBsAg levels predict response to PEG-IFN in patients with hepatitis B e antigen (HBeAg)-positive chronic
Quantitative hepatitis B surface antigen (qHBsAg) and quantitative hepatitis B e antigen (qHBeAg) titers are emerging as useful tools for measuring viral loads and for predicting the virological response (VR) and serological response (SR) to pegylated interferon therapy. However, the clinical utilit